Effectiveness of Subcutaneously Administered Leuprolide Acetate to Achieve Low Nadir Testosterone in Prostate Cancer Patients

Evidence suggests lower nadir testosterone levels during the first year of androgen deprivation therapy improve advanced prostate cancer clinical outcomes. We evaluated pivotal trials for subcutaneously administered leuprolide acetate (1-, 3-, 4-, and 6-month doses) to determine nadir testosterone l...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Rev Urol
Huvudupphovsmän: Pieczonka, Christopher M., Twardowski, Przemyslaw, Renzulli, Joseph, Hafron, Jason, Boldt-Houle, Deborah M., Atkinson, Stuart, Eggener, Scott
Materialtyp: Artigo
Språk:Inglês
Publicerad: MedReviews, LLC 2018
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6168320/
https://ncbi.nlm.nih.gov/pubmed/30288142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3909/riu0798
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk